Π‘ΠΈΠ½ΠΎΠ²ΠΈΠ°Π»ΡΠ½Π°Ρ ΡΠ°ΡΠΊΠΎΠΌΠ°: ΠΈΠΌΠΌΡΠ½ΠΎΠ³ΠΈΡΡΠΎΡ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ, Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ°
![ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ: Π‘ΠΈΠ½ΠΎΠ²ΠΈΠ°Π»ΡΠ½Π°Ρ ΡΠ°ΡΠΊΠΎΠΌΠ°: ΠΈΠΌΠΌΡΠ½ΠΎΠ³ΠΈΡΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ, Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ°](https://westud.ru/work/2515506/cover.png)
V ' ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΠΠΠ ΠΈ ΠΏΠ°Π½-ΡΠΈΡΠΎΠΊΠ΅ΡΠ°ΡΠΈΠ½Π° ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°Π΅ΡΡΡ Π² ΠΠ‘Π‘ ΡΠΈΠΏΠΈΡΠ½ΠΎΠ³ΠΎ ΡΡΡΠΎΠ΅Π½ΠΈΡ, Π° Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π½ΠΈΠ·ΠΊΠ°ΡΠ² ΠΠ‘Π‘ ΠΌΠ΅Π»ΠΊΠΎΠΊΡΡΠ³Π»ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΈ ΠΌΠΎΠ½ΠΎΠΌΠΎΡΡΠ½ΠΎ-Π²Π΅ΡΠ΅ΡΠ΅Π½ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΡΡΠΎΠ΅Π½ΠΈΡ. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ ΠΌΠΎΠΆΠ½ΠΎ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠΈΡΡ, ΡΡΠΎ Π² ΠΠ‘Π‘ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ Ρ ΠΏΡΠΈΠ·Π½Π°ΠΊΠ°ΠΌΠΈ ΡΠΏΠΈΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π½ΠΎΡΠΈΠΏΠ° ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅Ρ ΡΡΠ΅ΠΏΠ΅Π½Ρ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²ΠΊΠΈ ΡΡΠΈΡ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ ΠΈ, ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎ, ΠΈΡ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΡΡΠΎΠ΅Π½ΠΈΠ΅. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠΈΠΏΠΈΡΠ½ΡΠΉ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΠΠ‘ΠΠ Π‘ΠΠΠ ΠΠ©ΠΠΠΠ
- ΠΠΠΠΠ I. ΠΠΠ Π€ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ― (ΠΠΠ‘Π’ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ―, Π£ΠΠ¬Π’Π ΠΠ‘Π’Π Π£ΠΠ’Π£Π ΠΠΠ―, ΠΠΠΠ£ΠΠΠΠΠ Π€ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ―) ΠΠΠΠΠΠΠ‘Π’ΠΠΠ Π‘ΠΠΠΠΠΠΠΠ¬ΠΠ«Π₯ Π‘ΠΠ ΠΠΠ (ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«)
- 1. 1. ΠΠΠ©ΠΠ Π‘ΠΠΠΠΠΠΠ―
- 1. 2. ΠΠΠ‘Π’ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ― ΠΠΠ Π’ΠΠΠ
- 1. 3. Π£ΠΠ¬Π’Π ΠΠ‘Π’Π Π£ΠΠ’Π£Π ΠΠΠ― Π₯ΠΠ ΠΠΠ’ΠΠ ΠΠ‘Π’ΠΠΠ
- 1. 4. ΠΠΠΠ£ΠΠΠ€ΠΠΠΠ’ΠΠΠΠ ΠΠΠΠΠΠ
- ΠΠΠΠΠ II. ΠΠΠ’ΠΠ ΠΠΠΠ« Π ΠΠΠ’ΠΠΠ« ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―
- ΠΠΠΠΠ III. Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π« Π‘ΠΠΠ‘Π’ΠΠΠΠΠ«Π₯ ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ
- 3. 1. ΠΠΠ€ΠΠΠΠ«Π Π‘ΠΠΠΠΠΠΠΠ¬ΠΠ«Π Π‘ΠΠ ΠΠΠΠ« (ΠΠΠ©ΠΠ Π‘ΠΠΠΠΠΠΠ―)
- 3. 1. 1. ΠΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΊΠ°ΡΡΠΈΠ½Π°
- 3. 1. 2. Π£Π»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 1. 3. ΠΡΠΌΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 2. ΠΠΠΠΠΠΠ ΠΠΠΠΠΠΠΠ― ΠΠΠΠΠΠΠ‘Π’ΠΠ ΠΠΠΠΠΠ«Π Π ΠΠΠΠ ΠΠΠ ΠΠΠΠΠ€ΠΠΠΠ«Π Π‘ΠΠΠΠΠΠΠΠ¬ΠΠ«Π Π‘ΠΠ ΠΠΠΠ« (ΠΠΠ©ΠΠ Π‘ΠΠΠΠΠΠΠ―)
- 3. 3. ΠΠΠ‘Π’ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ― ΠΠΠ Π’ΠΠΠ
- 3. 4. ΠΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° Π²Π΅ΡΠ΅ΡΠ΅Π½ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΡΠ°ΡΠΊΠΎΠΌ Ρ ΠΏΡΠ΅Π²Π΄ΠΎΡΠΏΠΈΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΡΠΌ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΎΠΌ
- 3. 4. 1. Π£Π»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 4. 2. ΠΠ»ΡΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 5. ΠΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° Π³Π΅ΠΌΠ°Π½Π³ΠΈΠΎΠΏΠ΅ΡΠΈΡΠΈΡΠΎΠΌΠΎΠΏΠΎΠ΄ΠΎΠ±Π½ΡΡ
ΡΠ°ΡΠΊΠΎΠΌ
- 3. 5. 1. Π£Π»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 5. 2. ΠΡΠΌΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 6. ΠΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΌΠ΅Π»ΠΊΠΎΠΊΡΡΠ³Π»ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΡΠ°ΡΠΊΠΎΠΌ
- 3. 6. 1. Π£Π»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 6. 2. ΠΡΠΌΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 7. ΠΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΌΠΎΠ½ΠΎΠΌΠΎΡΡΠ½ΠΎ-ΠΎΠ²Π°Π»ΡΠ½ΠΎ ΠΈ/ΠΈΠ»ΠΈ Π²Π΅ΡΠ΅ΡΠ΅Π½ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΡΠ°ΡΠΊΠΎΠΌ
- 3. 7. 1. Π£Π»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 7. 2. ΠΡΠΌΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 1. ΠΠΠ€ΠΠΠΠ«Π Π‘ΠΠΠΠΠΠΠΠ¬ΠΠ«Π Π‘ΠΠ ΠΠΠΠ« (ΠΠΠ©ΠΠ Π‘ΠΠΠΠΠΠΠ―)
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ°ΡΠ΅Π½ΠΊΠ°Π»Ρ Π., ΠΠ΅ΡΠ΅Π²ΠΎΡΠΈΠΊΠΎΠ² Π. Π., Π Π°ΠΉΡ Π»ΠΈΠ½ Π. Π’. ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎ-ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠΎΠ½ΠΎΡΠ°Π·Π½ΡΡ Π²Π΅ΡΠ΅ΡΠ΅Π½ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ ΡΠΈΠ½ΠΎΠ²ΠΈΠ°Π»ΡΠ½ΡΡ ΡΠ°ΡΠΊΠΎΠΌ. ΠΡΡ . ΠΏΠ°Ρ.-1984 Π³- 4- 44−50.
- ΠΡΠ°Π΅Π²ΡΠΊΠΈΠΉ Π.Π., Π‘ΠΌΠΎΠ»ΡΡΠ½Π½ΠΈΠΊΠΎΠ² Π. Π., Π‘Π°ΡΠΊΠΈΡΠΎΠ² Π. Π‘. ΠΠ°ΡΠΎΠ»ΠΎΠ³ΠΎ-Π°Π½Π°ΡΠΎΠΌΠΈΡΠ΅ΡΠΊΠ°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ Π΄Π»Ρ Π²ΡΠ°ΡΠ΅ΠΉ. ΠΠΎΡΠΊΠ²Π°-1993Π³- ΡΠΎΠΌ 1- 315−327.
- ΠΠ΅ΡΡΠΎΠ² Π‘.Π., Π Π°ΠΉΡ Π»ΠΈΠ½ Π. Π’. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΠ³ΠΈΡΡΠΎΡ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. ΠΠ°Π·Π°Π½Ρ-2004 Π³.
- Π Π°ΠΉΡ Π»ΠΈΠ½ Π.Π’., ΠΠ°Π²ΠΈΠ΄ Π., ΠΠ°ΠΏΠΈΡ Π. Π£Π»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ° ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ. ΠΠΎΡΠΊΠ²Π°- 1981 Π³- 13−20.
- Π―Π³ΡΠ±ΠΎΠ² Π.Π‘., ΠΠ°Ρ Π.Π. ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½Π°Ρ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΠΌΡΠ³ΠΊΠΈΡ ΡΠΊΠ°Π½Π΅ΠΉ. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ. ΠΠΎΠ²ΠΎΡΠΈΠ±ΠΈΡΡΠΊ-1984 Π³- 112−127.
- Aziza J, Mazerolles C, Selves J et al. Comparison of the reactivities of monoclonal antibodies QBEND 10 (CD34) and BNH9 in vascular tumors. Appl. Immunohistochem. 1993- 1- 51−57.
- Antonescu CR, Tschernyavsky SJ, Woodruff JM et al. An immunohistochemical analysis of clear cell sarcoma. J. Mol. Diagn. 2002- 4- 44−52.
- Antonescu CR, Argani P, Erlandson RA et al. Skeletal and extraskletal myxoid chondrosarcoma: a comparative clinicopathologic, immunologic and ultrastructural study. Cancer. 1998- 83- 1504−1521.
- Antonescu CR, Busam KJ, Iversen Π I et al. MAGE antigen expression in monophasic and biphasic synovial sarcoma. Hum Pathol. 2002- 33- 225−9.
- Achim A, Jungbluth, Biisam et al. Expression of MAGE-antigens in normal tissue and cancer, lnt J Cancer. 2000- 85- 460−465.
- Brooks JS. Immunohistochemistry in the differential diagnosis of soft tissue tumors. Monogr. Pathol. 1996- 38- 65−128.
- BarnoudR, Delattre O, Peoc’h M et al. Desmoplastic small round cell tumor: RT-PCR analysis and immunohistochemical detection of the Wilm’s tumor gene WT1. Pathol Res. Pract. 1998- 194- 693−700.
- Bacchi CE, Bonetti F, Pea M et al. Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 1995- 128- 563 576.
- Cappello F, Bellafiore M, Bucchieri F et al Poorly differentiated synovialsarcoma. Pathol Oncol Res. 2001- 7- 63−6.
- Chan JK. Advances in immunohistochemistry: impact on surgical patology practice. Semin.Diagn.Pathol. 2000- 17- 170−177.
- Coindre JM, de Mascarel A, De Trojani MM. Immunohistochemistry in the diadnosis of soft tissue tumors. J. Histopathol. 2003- 43- 1−16.
- Cui S, Hano H, Harada T et al. Evalution of new monoclonal anti-MyoDl and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol. Int. 1999- 49- 62−68.
- Chase DR, Enzinger FM, Weiss SW et al. Keratin in epithelioid sarcoma. An immunohistochemical study. Am. J. Surg. Pathol. 1984- 8- 435−441.
- Dardick I, Ramjohn S, Thomas MJ et al. Synovial sarcoma. Inter-relationship of the biphasic and monophasic subtypes. Pathol Res Pract. 1991- 187(7) — 871−85.
- De Silva M V C, McMahon A D, Pater son L et al. Identification of poorly differentiated synovial sarcoma. Histopathology. 2003- 43- 220−230.
- Dalerba P, Frascella E, Macino Π et al. MAGE, BAGE an GAGE gene expression in human tumors. Cancer Res. 2000- 60(14) — 3848−55.
- Dei Tos ΠΠ , Wadden Π‘, Fletcher CD. S-100 protein staining in synovial sarcoma. Appl. Immunohistochem. 1997- 5- 73−77
- Dei Tos AP, Wadden C, Calonje E. Immunohistoehemieal demonstration of glycoprotein p30/32 (MIC2) (CD99) in synovial sarcoma: a potential cause of diagnostic confusion. Appl. Immunohistochem. 1995- 3- 168−173.
- Dias P, Parham DM, Shapiro DN et al. Myogenic regulatory protein (MyoDl) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am. J. Pathol. 1990- 137- 1283−1291.
- Dias P, Chen B, Dilday Π et al. Strong immunostaining for MyoDl in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am. J. Pathol. 2000- 156- 399−408.
- De Yong BR, Wick MR, Fitzgibbon J et al. CD 31: an immunospecific marker for endothelial differentiation in human neoplasms. Appl. Immunohistochem. 1993- 1- 97−100.
- Flieder DB., Moran CA. Primary cutaneous synovial sarcoma. Am. J. Dermatopathol. 1998.-Vol 20(5). P. 509−12.
- Fletcher CD. The use of immunohistochemistry in the diagnosis of soft tissue tumors. Histopatology. 1986- 10- 771−773.
- Fisher C. Synovial sarcoma: ultrastructural and immunohistoehemieal features of epithelial differentiation in monophasic and biphasic tumors. Hum. Pathol. 1986- 17- 996−1008.
- FolpeAL, Hill CE, Weiss SW. Immunohistoehemieal detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing’s sarcoma/primitive neuroectodermal tumor. Am. J. Surg.Pathol. 2000- 24- 1657−1662.
- Folpe AL., Schmidt RA. Poorly differentiated synovial sarcoma: immunohistoehemieal distinction from primitive neuroectodermal tumors andhigh-grade malignant peripheral nerve sheath tumors. Am. Surg.Pathol. 1998- 22- 673−682.
- Folpe AL, Weiss SIV, Fletcher CD et al. Tenosinovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation. Mod. Pathol. 1998- 11- 939−944.
- Fellinger EJ, Garin-Chesa P, Triche TJ et al. Immunohistochemical analysis of Ewing’s sarcoma cell surface antigen p30/32 MIC 2. Am.J. Pathol. 1991- 139- 317−325.
- Fechner R.E. Neoplasms and Neoplasia-like lesions of the Synovium. Monograph. 1976- 17- 173−176.
- Goos N. P, Van Muijen, Dirk J. Ruite. et al. Cancer/ testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma. Am J Pathol. 1994- 114- 9−17.
- Gu M, Antonescn CR, Guiter G. Cytokeratin immunoreactivity in Ewing’s sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am. J. Surg.Pathol. 2000- 24- 410−416.
- Guarino M, Tricomi P, Giordano F, Cristofori E. Sarcomatoid carcinomas: pathological and histopathogenetic considerations. Pathology 1996- 28- 298−305.
- Gidlloii L, Wadden C, Kraus M et al. S-100 protein reactivity in synovial sarcomas. A potentially frequent diagnosis pitfall. Immunohistochemical analysis of 100 cases. Appl. Immunohistochem. 1996- 4- 167−175.
- Gray MH, Rosenberg AE, Dickersin GR et al. Cytokeratin expression in epithelioid vascular neoplasms. Hum. Pathol. 1990- 21- 212−217.
- Hiraga H, Nojima T, Abe S et al. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors. Diagn. Mol. Pathol. 1998- 7- 102−110.
- ΠΠ°ΠΏΠ°ΠΈ Π‘ A, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum. Pathol. 1995- 26- 440−449.
- Hasegawa T, Matsuno Y, Shimoda et al. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum. Pathol. 1999- 30- 1464−1473.
- Ishida Π Matsumura T, Salgaller ML et al MAGE-1 and MAGE-3 or MAGE-6 expression in neuroblastoma-related pediatric solid tumors. J Cancer. 1996- 69(5) — 375−80.
- Ichinose Π., Powell I., Hoerner H.E. et al Cancer Res. 1989- 39- 4270−4273.
- Jones H, Sterart PV, Du Boulay CE et al. Alpha-smooth muscle actin as a marker for soft tissue tumors: a comparison with desmin. J. Pathol. 1990- 162- 2933.
- J M Coindre. Immunohistochemistry in the diagnosis of soft tissue tumors. J Histopatology. 2003- 43- 1−16.
- Jungbluth AA, Antonescu CR, Busam KJ et al Monophasic and biphasic synovial sarcomas abundantly express cancer/ testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Am J Pathol. 2000- 21 (2) — 164−73.
- Jorgensen LJ, Lyon H, Myhre-Jensen Π et al Synovial sarcoma. An immunohistochemical study of the epithelial component. APMIS. 1994−102(3) — 191−6.
- Krane JF, Bertoni Fr Fletcher CD et al. Myxoid synovial sarcoma. J Mod Pathol. 1999- 12(5) — 456−62.
- Kilpatrick SE, Hitchock MG, Kraus MD. Mixed tumors and myoepitheliomas of the skin and soft tissue: a clinicopathologic study of 19 cases with a unifying concept. Am.J.Surg.PathoI. 1997- 21- 13−22.
- Kahn HJ, Marks A, Thorn H. Role of antibody to S-100 protein in diagnostic pathology. Am.J.Clin.Pathol. 1993- 79- 341−347.
- Kumar S, Perlman E, Harris CA et al. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistoehemieal study in paraffin-embedded tissues. Mod. Pathol. 2000- 13- 988−993.
- Kindblom LG, Lodding P, Angervall L. Clear-cell sarcoma of tendons and aponeuroses. An immunohistoehemieal and electron microscopic analysis indicating neural crest origin. Virchows Arch. A Pathol. Anat. Histopathol. 1993- 401- 109−128.
- Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcomas. Hum.Pathol. 2000- 31- 532−538.
- Lewis JE, Olsen KD, Sebo TJ. Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistiy. Hum. Pathol. 1997- 28- 664−673.
- Lopes JM, Bjerkehagen B, Holm R. Immunohistoehemieal profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumors, reccurences and metastases. Pathol. Res. Pract. 1994- 190- 168 177.
- Lae ME, Roche PC, Jin L et al. Desmoplastic small round cell tumor: a clinicopathologic, immunohistoehemieal study of 32 tumors. Am. J. Surg. Pathol. 1998- 22- 1314−1327.
- Laskin WB, Weiss SW, Bratthauer GL et al. Epithelioid variant malignant peripheral nerve sheath tumor. Am. J. Surg. Pathol. 1991- 15- 1136−1145.
- Martelange V, De Smet C, De Plaen E et al. Identification on a human sarcoma of two new genes with tumor-specific expression. Diagn Mol Pathol. 1998- 7(1) — 16−23.
- Miettinen M, Virtanen I. Synovial sarcoma—a misnomer. Am J Pathol. 1984- 17(1) — 18−25.
- Miettinen M. Immunohistochemistry of soft-tissue tumors. Possibilities and limitations in surgical pathology. Pathol.Annu. 1990- 25- 1−36
- Miettinen M, Limon J, Niezabitowski A et al. Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch. 2000- 437- 275−283.
- Miettinen M, Fanburg-Smith JC, Virolainen M. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion ofthedifferential diagnosis. Hum. Pathol. 1999- 30- 934−942.
- Michal M, Miettinen M. Myoepitheliomas of the soft tissues. Virchows Arch. 1999- 434- 393−400.
- Miettinen M. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma. Arch. Pathol. Lab. Med. 1988- 112- 637−640.
- Miettinen M, Rapola J. Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomiosarcoma-like tumors. Expression of cytokeratin and the 68-kd neurofilament protein. Am. J. Surg.Pathol. 2000- 24- 410−416.
- Miettinen M, Fetsch JF. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis. Hum. Pathol. 2000- 31- 1062−1067.
- Montgomery E, Meis JM, Ramos et al. Clear cell sarcoma of tendons and aponeuroses. A clinicopathologic study of 58 cases with analysis of prognostic factors. Int. J.Surg. Pathol. 1993- 1- 89−100.
- Matsunou H, Shimoda T, Kakimoto S. Histopatohologic and immunohistochemical study malignant tumors of peripheral nerve sheath. Cancer. 1995- 56- 2269−2279.
- Meis-Kindblom JM, Bergh P, Gunterberg Π et al. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am. J.Surg.Pathol. 1999- 23- 636−650.
- Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD 31 and CD 34. Mod. Pathol. 1994- 7- 82−90.
- Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am. J. Surg. Pathol. 1998- 22- 683−697.
- Noguera R, Navarro S, Cremades A et al. Translocation (x-18) in biphasic synovial sarcoma with morphologic features of neural differentiation. Diagn Mol Pathol. 1998−7(4) — 232−3.
- Nielsen GP, Π 'Connel JX, Dickersin et al. Solitary fibrous tumor of soft tissue: a 15 report of cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod. Pathol. 1997- 10- 1028−1037.
- Ordonez NG, Mahfouz SM, Mackay B. Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum Pathol. 1990- 21(7) — 733−49.
- Ordonez NG. Application of immunocytochemistry in the diagnosis of soft tissue sarcomas sarcomas- a review and update. Adv. Anat. Pathol. 1998- 5- 67−85.
- Okamoto S, Hisaoka M, Ishida T et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum. Pathol. 2001- 32- 1116−1124.
- Ordonez NG. Desmoplastic small round cell tumor: An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am. J. Surg. Pathol. 1998- 22- 1314−1327.
- Pelmus M, Guillou L, Hostein I. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t (X-18)(SYT-SSX)-positive cases. Am J Surg Pathol. 2002- 26(11) — 1434−40.
- Porter PL, Bigler SA, McNutt M et al. The immunophenotype of hemangiopericytomas, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod. Pathol. 1991- 4- 4652.
- Pritchard PJ, Soule EH, Taylor WF et al. Fibrosarcoma- A clinicopathologic and statistical study of 199 tumors of the soft tissue of the extremities and trunk. Cancer. 1994- 33- 888−99.
- Perlman EJ, Dickman PS, Askin et al. Ewing’s sarcoma-routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Hum. Pathol. 1994- 25- 304−307.
- Roholl PJ, De Jong AS, Ramaekers FG. Application of markers in the diagnosis of soft tissues tumors. Histopatology. 1985- 9- 1019−1035.
- Rangdaeng S, Truong LD. Comparative immunohistochemical staining for desmin and muscle-specific actin. A study of 576 cases. Am. J. Clin.Pathol. 1991- 96- 32−45.
- Ramani P, Rampling D, LinkM. Immunohistochemical study of 12 E7 in small round-cell tumors of childhood: an assessment of its sensitivity and specificity. Histopathology. 1993- 23- 557−561.
- Renshaw AA. 013 (CD99) in spindle cell tumors. Reactivity with hemangiopericytoma, solitary fibrous tumor, synovial sarcoma, and meningioma but rarely with sarcomatoid mesothelioma. AppLImmunohistochem. 1995- 3- 250 256.
- Riopel M, Dickman PS, Link MP et al. MIC2 analysis in pediatric lymphomas and leukemias. Hum. Pathol. 1994- 25- 396−399. 3
- Sudo T, Kuramoto T, Komiya S et al. Expression of MAGE genes in osteosarcoma. J Orthop Res. 1997- 15(1) — 28−32.
- Suster S. Recent advances in the application of immunohistochemical markers for the diagnosis of soft tissue tumors. Semin. Diagn. Pathol. 2000- 17- 225−235.
- Smith Π’Π, Machen SK, Fisher Π‘ et al. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor. Am.J. Clin. Pathol. 1999- 112- 641−648.
- Schitt FC, Bacchi CE. S-100 protein: is it useful as a tumor markers in diagnostic immunohistochmemisry? Histopathology. 1989- 15- 281−288.
- Somerhausen NS, Fletcher CD. Diffuse-type giant cell tumor: clinipathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am. J. Surg. Pathol. 2000- 24- 479−492.
- Suster S, Rosai J. Intranodal hemorrhagic spindle-cell tumor. Report of six cases of a distinctive mesenchymal neoplasm of the inguinal region that simulates Kaposi’s sarcoma. Am. J. Surg. Pathol. 1989- 13- 347−357.
- Shanfeld RL, Edelman J, Willis JE et al. Immunohistochemical analysis of neural markers in peripheral primitive neuroectodermal tumors (pPNET) without light microscopic evidence of neural differentiation. Appl. Immunohistochem. 1997- 5- 78−86.
- Trassard M., Le Doussal V., Hacene K. et al. Prognostic factors in localized primary synovial sarcoma. J Clin Oncol. 2001- 19(2) — 525−34.
- TaxyJ, BattiforaH. In: Diagnostic Electron Microscopy. Ed. B. F. Trump, R.T. Jones. 1980- 3- 97−174.
- Wright P. H, Sim F, Soule. Ultrastructural study of synovial sarcomas. J. Bone JT. Surg. 1982- 64-A- 112−122.
- Weintraub H, Davis R, Tapscott S et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 1991- 251- 761−766.
- Wrba F, Fertl H, Amann G. Epithelial markers in synovial sarcoma. An immunohistochemical study on paraffin embedded tissues. Virchows Arch. A Pathol. Anat. Histopathol. 1989- 415- 253−258.
- Wijnaendts LC, van der Linden JC, van Unnik et al. The expression pattern of contractile and intermediate filament proteins in developing skeletal muscle and rhabdomyosarcomas: diagnostic and prognostic utility. J. Pathol. 1994- 174- 283
- Wang NP, Marx J, McNutt MA et al. Expression of myogenic regulatory proteins (myogenin and MyoDl) in small round cell tumors. Am. L Pathol. 1995- 147- 1799−1810.
- Wesche WA, Fletcher CD, Dias P et al. Immunohistochemistry of MyoDl in adult pleomorphic soft tissue sarcomas. Am. J. Surg. Pathol. 1995. 19- 261−269.
- Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am. J. Surg. Pathol. 1994. 18. 992 292.